Qian Mo

Prof. Qian Mo


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
BLBaoyan Liu
Baoyan Liu
YWYang Wang
Yang Wang
HXHuanfang Xu
Huanfang Xu
YCYuelai Chen
Yuelai Chen
JWJiani Wu
Jiani Wu
ZLZhishun Liu
Zhishun Liu
In women with mixed urinary incontinence, pelvic floor muscle training and solifenacin is the recommended conservative treatment, while electroacupuncture is a safe, economical and effective option. In this prospective, multi-center, randomized controlled trial, five hundred women with mixed urinary incontinence, from 10 centers will be randomized to receive either electroacupuncture or pelvic floor muscle training plus solifenacin. Women in the acupuncture group will receive electroacupuncture for 3 sessions per week, over 12 weeks, while women in the control group will receive pelvic floor muscle training plus solifenacin (5 mg once daily) for 36 weeks. The primary outcome measure is the proportion of change in 72-hour incontinence episode frequency from baseline to week 12. The secondary outcome measures include eleven items, including proportion of participants with ≥50% decrease in average 72-h incontinence episode frequency, change from baseline in the amount of urine leakage and proportion of change from baseline in 72-h incontinence episode frequency in week 25–36, and so forth. Statistical analysis will include covariance analysis, nonparametric tests and t tests. The objective of this trial is to compare the efficacy and safety of electroacupuncture versus pelvic floor muscle training plus solifenacin in women with moderate and severe mixed urinary incontinence. ClinicalTrials.gov Identifier: NCT02047032

1 March 2021 in Journal of Integrative Medicine
Verified
Journal Article
Open access
NZNa Zhi
Na Zhi
QMQian Mo
Qian Mo
SYShuo Yang
Shuo Yang
YQYuan-Xing Qin
Yuan-Xing Qin
HCHao Chen
Hao Chen
YLYin-Long Li
Yin-Long Li
After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient’s condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.

23 July 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
BLBaoyan Liu
Baoyan Liu
YWYang Wang
Yang Wang
JWJiani Wu
Jiani Wu
QMQian Mo
Qian Mo
WWWeiming Wang
Weiming Wang
ZLZhishun Liu
Zhishun Liu
Acupuncture is safe and may be effective for severe chronic constipation. The World Gastroenterology Organisation recommends prucalopride for patients for whom previous laxative use failed to provide satisfactory relief. In this prospective, multi-centre, randomised controlled trial, five hundred sixty patients with severe chronic constipation (two or less spontaneous complete bowel movements per week) from 14 centres will be randomised to receive either electroacupuncture or prucalopride. Participants in the electroacupuncture group will receive electroacupuncture for eight weeks, while participants in the control group will take prucalopride (2 mg once daily) for 32 weeks. The primary outcome measure is the proportion of patients having ≥3 spontaneous, complete bowel movements per week, averaged over week three to eight. The secondary outcome measures include eight items, including the proportion of patients having ≥3 spontaneous, complete bowel movements per week averaged over week 9–32, the proportion of patients with one or more increases in spontaneous, complete bowel movements per week from baseline, mean Bristol Stool Scale, etc. Statistical analysis will include the CMH test, nonparametric tests and t tests. We aimed to compare the effect of electroacupuncture versus prucalopride for severe chronic constipation. The limitation of this study is that participants and acupuncturists will not be blinded. ClinicalTrials.gov Identifier: NCT02047045 .

1 February 2020 in Medicine
Verified
Journal Article
Open access
YHYu Huang
Yu Huang
SQShuangjin Qi
Shuangjin Qi
XWXianming Wu
Xianming Wu
NZNa Zhi
Na Zhi
THTing He
Ting He
QMQian Mo
Qian Mo
Background: Despite that the urge urinary incontinence (UUI) is a nonfatal disease, it can lead to anxiety, embarrassment and depression to the patient. UUI is a common public health problem that can significantly affect the quality of life of the patient. Several conservative treatments have been recommended for the treatment of UUI; however, their efficiency remains unclear, leaving the disease without a real effective treatment. The clinical application of acupuncture to treat UUI is currently considered an effective approach despite the limited evidence that support its efficiency. The aim of this study is to assess the efficacy and safety of electroacupuncture therapy in the treatment of UUI. Methods and analysis: A randomized, parallel, controlled study will be performed. Patients with UUI treated with electroacupuncture group (EA) will compare with the sham-treated sham EA (SA) patients. A total of 100 participants with UUI will be randomly allocated to either the EA or the SA group with a 1:1 ratio. The treatment of UUI patients will performed 3 times per week, for 8 weeks in 30-minute sessions. At the end of the treatment the patients will be followed-up until week 32. The primary outcomes include scores of incontinence questionnaire-short form, the average 24-hour urgency incontinence episodes, and the average 24-hour urge episodes responses from baseline until the 4th, 8th , 24th, and 32nd week. The secondary outcomes included the average 24-hour urine volume and the average 24-hour micturition frequency responses from baseline until the 8th and 32nd week, as well as the change in incontinence quality of life scores from baseline at the 8th and 32nd week. In addition, the degree of satisfaction of the participants undergoing acupuncture treatment will be measured at the 4th and 8th week. The participants’ clinical acupuncture expectations were evaluated at baseline, and the questionnaire for urinary incontinence diagnosis was used to identify stress incontinence, mixed urinary incontinence, and urge incontinence at baseline. Discussion: This is a randomized, controlled, observer-blinded trial of electroacupuncture treatment for UUI. The results of this trial will provide more evidence on whether electroacupuncture is efficacious for treating UUI.

12 March 2026 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
YHYu Huang
Yu Huang
JCJianying Chang
Jianying Chang
XWXianming Wu
Xianming Wu
GHGuishuang He
Guishuang He
QGQin Guo
Qin Guo
QMQian Mo
Qian Mo
Cancer-related fatigue is highly prevalent among cancer patients. This study aimed to evaluate the effects of acupuncture on fatigue levels and quality of life in breast cancer patients with cancer-related fatigue. This pilot study employed a double-center, randomized, single-blind, placebo-controlled design. A total of 68 breast cancer patients with cancer-related fatigue who fulfilled the inclusion criteria were recruited and randomly allocated into either an acupuncture group (n = 34) or a sham acupuncture group (n = 34). Both groups selected the same acupoints: CV12, CV4, CV6, LI4 (bilaterally), KI3 (bilaterally), ST36 (bilaterally), and SP6 (bilaterally). The acupuncture group employed traditional acupuncture techniques to insert needles into the acupoints to elicit the deqi sensation. By contrast, the sham acupuncture group utilized blunt needles that did not penetrate the skin. Both groups underwent a 6-week treatment regimen consisting of 20 sessions (4 sessions per week during weeks 1–3 (approximately every other day) and a total of 8 sessions during weeks 4–6 (2–3 sessions per week, every 2–3 days), each lasting 30 min). Changes in scores on the brief fatigue inventory (BFI), fatigue scale-14 (FS-14), and hospital anxiety and depression scale (HADS) were assessed at week 0, 6, 8, and 10. Additionally, compliance with and safety of acupuncture were documented. Research variables between the two groups were compared using a significance level of p < 0.05. The study revealed a time-dependent therapeutic advantage of acupuncture over sham acupuncture. While both groups showed similar short-term reductions in fatigue (BFI: acupuncture 6.69 ± 1.66 vs. sham acupuncture 6.19 ± 1.60; between-group p = 0.223) and psychological distress at week 6 after treatment, acupuncture demonstrated progressively amplified benefits. During the 10-week follow-up period, acupuncture achieved significantly greater reductions in fatigue severity (BFI: Δ = -1.28, p = 0.011; FS-14: Δ = -1.81, p = 0.003) and psychological symptoms (HADS-A: Δ = -2.06, p = 0.006; HADS-D: Δ = -1.81, p = 0.003), with intergroup differences widening over time (week 8 vs. week 10). Both groups exhibited full compliance, and acupuncture-related adverse events were limited to mild ecchymosis (9.4%). These findings suggest acupuncture induces time-dependent modulation beyond placebo effects. Acupuncture can sustainably and effectively alleviate fatigue symptoms in cancer patients, improve their anxiety and depressive symptoms, and demonstrate high safety and compliance. This clinical trial was prospectively registered in the Chinese Clinical Trial Registry (ChiCTR2300069361; 14/03/2023) (https://www.chictr.org.cn/). The online version contains supplementary material available at 10.1186/s12906-026-05341-2.